Sawai Pharmaceutical’s $1.05 Billion Acquisition of the Generics Business of Upsher-Smith Laboratories

Ambrogio Visconti
Tagged:

Debevoise & Plimpton LLP is advising Sawai Pharmaceutical Co. Ltd., a leading Japanese generic pharmaceuticals manufacturer, in its $1.05 billion acquisition of the generic pharmaceuticals business…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here